Angus Liu
2020-01-24
healthcare
FiercePharmaAsia—Amgen-Astellas JV; Hengrui's new chairman; coronavirus vaccine development
On the heels of a China team-up with BeiGene, Amgen is on track to run a Japanese operation independently after buying out an Astellas joint venture. Sun Piaoyang has stepped down as Jiangsu Hengrui Medicine's chairman after leading—and making a fortune from—the Chinese pharma major for 30 years. Moderna and Inovio are utilizing their novel platforms to develop vaccines against the new coronavirus that's emerged in China. And more.
